MTOR and breast cancer: To define the molecular mechanisms underlying the trastuzumab resistance mediated by HOTAIR, HER2 receptor signaling pathway related, PI3K/AKT/mTOR and MEK/MAPK, have been analyzed in the sensitive and resistant BC cells.